共 50 条
Practical considerations when treating chronic hepatitis E in solid organ transplant recipients
被引:0
|作者:
Choi, David K.
[1
]
Martin, Michelle T.
[1
]
Chacra, Wadih
[2
]
Chan, Christine
[2
]
Koppe, Sean
[2
]
Landers, Lisa
[2
]
Naveed, Ammara
[2
]
Mikolajczyk, Adam E.
[2
]
机构:
[1] Univ Illinois, Coll Pharm, 833 S Wood St,Suite 164,M-C 886, Chicago, IL 60612 USA
[2] Univ Illinois, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL USA
关键词:
Hepatitis E virus;
Liver transplant;
Ribavirin;
Transplant;
D O I:
10.1007/s11096-020-01195-x
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Hepatitis E virus (HEV) can lead to chronic infections in immunosuppressed patients. The use of ribavirin to treat chronic HEV has been well-established in case reports and guidelines. However, practical approaches to the use of this antiviral treatment in a post-transplant patient, including drug interactions, dosing adjustments, and monitoring parameters, are lacking. Thus, we present our real-world approach to the use of ribavirin to treat chronic HEV in a solid organ transplant recipient.
引用
收藏
页码:753 / 755
页数:3
相关论文